ACM
OLMA icon

Aquatic Capital Management’s Olema Pharmaceuticals OLMA Stock Holding History

Aquatic Capital Management’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.66M Buy
111,186
+95,872
+626% +$2.13M 0.05% 428
2025
Q4 		$383K Buy
+15,314
New +$273K 0.01% 815
2025
Q1 		– Sell
-31,565
Closed -$184K – 1538
2024
Q4 		$184K Buy
+31,565
New +$315K 0.01% 951

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Aquatic Capital Management's OLMA Position: Q1 2026 in Review

Aquatic Capital Management increased its Olema Pharmaceuticals (OLMA) stake by 626% in Q1 2026, buying an estimated $2.13M and bringing the position to 111,186 shares worth $1.66M. The position accounts for 0.05% of the portfolio, ranked #428.

Aquatic Capital Management first reported a position in OLMA in Q4 2024 and has held it in 3 quarters since. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • Aquatic Capital Management held 111,186 shares of Olema Pharmaceuticals worth $1.66M as of Q1 2026.
  • Aquatic Capital Management bought 95,872 Olema Pharmaceuticals shares in Q1 2026, an estimated $2.13M.
  • Olema Pharmaceuticals made up 0.05% of Aquatic Capital Management's portfolio in Q1 2026, its #428 holding.
  • Aquatic Capital Management first reported a position in Olema Pharmaceuticals in Q4 2024 and has held it in 3 quarters since.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on Aquatic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.